GSK's Zeffix slows liver cirrhotic progress.
Published: 2003-11-14 06:56:00
Updated: 2003-11-14 06:56:00
A sustained medication of GSK's Zeffix may significantly slow the progress of liver diseases complicated with a chronic "B" virus hepatitis, a researcher reported recently at the 54th annual conference of the American Society of Liver
Dr. Liau Yoon, internist of Changkoong Memorial Universit...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
